Randall Kaye, Chief Medical Officer at Axsome Therapeutics, Inc. (AXSM), bought 1,000 shares at $9.03 ($9K) on 2015-12-23, disclosed to the SEC on 2015-12-24.
Open-market purchase of $9k AXSM by Chief Medical Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| LBPH | SELL | 2024-08-13 | $1.2M | — | Filing → |
| LBPH | BUY | 2024-08-13 | $2K | — | Filing → |
| AVNR | SELL | 2011-09-13 | $275K | — | Filing → |